Ebaa Al Ozairi, MD
Dasman Diabetes Institute
5
4
0
N/A
0
6
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (5)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Kay Scarsbrook Khan, BSc
Dasman Diabetes Institute
Shared therapeutic areas:
Worked with same sponsors:
Adrian Vella, MD
Mayo Clinic
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Aisha Razzaq, MSPT-OMPT
Riphah International University
Shared therapeutic areas:
Lisa Porter, MD
Amylin Pharmaceuticals, LLC.
Shared therapeutic areas:
ali ismail, lecturer
Cairo University
Shared therapeutic areas:
David Crowley, MD
KGK Science Inc.
Shared therapeutic areas:
Samuel Klein, MD
Washington University School of Medicine
Shared therapeutic areas:
Shirley Wang, PhD, ScM
Brigham and Women's Hospital
Shared therapeutic areas:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (5)
Showing 5 of 5 trials
Tirzepatide Use in People With Obesity and Type 1 Diabetes
Compare Multiple Daily Injections With Carbohydrate Counting or With Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes
Postprandial Glucose Response Using Mass-Market No-Added-Sugar Ice Cream
A Feasibility Study Comparing Usual Foot Education and Phone App Alerts in Patients With Increased Risk of Diabetic Foot
Structured Education Program and Glycemic Control in Adolescents With Type 1 Diabetes
All 5 trials loaded